Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The complex cartography of stem cell commitment.

Koichi Akashi1, David Traver, Leonard I Zon

  • 1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Cell
|April 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Investigation of Angiogenesis and Its Prevention by Small Compounds in a Zebrafish Cancer Model.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell Intravasation.

Cancer cell·2024
Same author

A multistep computational approach reveals a neuro-mesenchymal cell population in the embryonic hematopoietic stem cell niche.

Development (Cambridge, England)·2024
Same author

Comparative transcriptomics coupled to developmental grading via transgenic zebrafish reporter strains identifies conserved features in neutrophil maturation.

Nature communications·2024
Same author

Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy.

Cell stem cell·2023
Same author

Dermomyotome-derived endothelial cells migrate to the dorsal aorta to support hematopoietic stem cell emergence.

eLife·2023
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Same journal

Systematic discovery of pathogen effector functions across human pathogens and pathways.

Cell·2026
See all related articles

Hematopoietic stem cells (HSCs) commit to early cell fates through the Flt3 receptor. This receptor marks the earliest point where HSCs lose potential to become erythrocytes and megakaryocytes, differentiating into lymphocyte progenitors.

Area of Science:

  • Hematology
  • Developmental Biology
  • Stem Cell Biology

Background:

  • Multipotent hematopoietic stem cells (HSCs) possess the unique ability to differentiate into all blood cell types.
  • Understanding the precise molecular mechanisms governing early lineage commitment in HSCs is crucial for regenerative medicine and treating hematological disorders.

Discussion:

  • The study by Adolfsson et al. investigates the role of Flt3 receptor tyrosine kinase in early hematopoietic stem cell differentiation.
  • Flt3 signaling is implicated as a critical factor in directing HSC fate decisions.
  • The research highlights the sequential loss of differentiation potential during HSC commitment.

Key Insights:

  • Flt3 is identified as the earliest known marker for hematopoietic cell fate commitment.

Related Experiment Videos

  • Erythrocyte and megakaryocyte potentials are lost sequentially as HSCs differentiate.
  • Commitment towards lymphocyte progenitors occurs early in the differentiation pathway, marked by Flt3 expression.

    • Outlook:

    • Further research into Flt3's downstream signaling pathways could reveal novel therapeutic targets.
    • This study provides a foundation for understanding lineage biases in HSC differentiation.
    • Investigating Flt3's role in other stem cell systems may offer broader insights into cell fate determination.